NCT04647721View on ClinicalTrials.gov

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

November 8, 2021

Study Completion Date

April 27, 2022

Conditions
Correction of Moderate to Severe Nasolabial Folds (NLFs)
Interventions
DEVICE

Radiesse injectable implant (dermal filler)

Subdermal injection.

DEVICE

Restylane injectable implant (dermal filler)

Subdermal injection.

Trial Locations (7)

100034

Peking University First Hospital, Merz Investigational Site #0860003, Beijing

310006

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Merz Investigational Site #0860030, Hangzhou

310014

Zhejiang Provincial People's Hospital, Merz Investigational Site #0860005, Hangzhou

430060

RenMin Hospital of Wuhan University, Merz Investigational Site #0860014, Wuhan

510000

The Third Affiliated Hospital, Sun Yat-Sen University, Merz Investigational Site #0860023, Guangzhou

Unknown

Peking University Third Hospital, Merz Investigational Site #0860009, Beijing

Zhongda Hospital Southeast University, Merz Investigational Site #0860022, Nanjing

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT04647721 - Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter